Oct 31, 2022 8:00 am EDT Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
Sep 27, 2022 8:00 am EDT Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
Aug 11, 2022 4:05 pm EDT Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update
Jul 28, 2022 8:00 am EDT Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
Jun 29, 2022 8:00 am EDT Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation
Jun 21, 2022 8:00 am EDT Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
Jun 1, 2022 8:00 am EDT Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
May 26, 2022 8:00 am EDT Achieve Life Sciences Announces Participation at LD Micro Invitational Conference